Acadia Healthcare Company, Inc. (ACHC)
$
22.91
-0.94 (-4.10%)
Key metrics
Financial statements
Free cash flow per share
-4.8640
Market cap
2.1 Billion
Price to sales ratio
0.6377
Debt to equity
1.3622
Current ratio
1.5502
Income quality
-0.1208
Average inventory
6 Million
ROE
-0.3942
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States and Puerto Rico, highlighting the company's operational efficiency with an EBITDA ratio of -0.22. The company's stock is identified with the symbol 'ACHC' in the market, allowing investors to track its performance effectively. Acadia reported a substantial revenue of $3,312,769,000.00 reflecting its strong market presence and ability to cater to diverse patient needs. The income before tax ratio stands at -0.32 illustrating the pre-tax margin and underlying profitability. Moreover, the company reported selling, general, and administrative expenses of $195,475,000.00 indicating its operational overhead costs as it manages a network of facilities that includes inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, Acadia operates 238 behavioral healthcare facilities with approximately 10,600 beds, demonstrating its commitment to offering comprehensive healthcare solutions. The stock is affordable at $22.14 making it suitable for budget-conscious investors looking for entry points in the market. With a high average trading volume of 3,690,372.00 the stock indicates strong liquidity, which appeals to active traders and long-term investors alike. With a mid-range market capitalization of $2,112,571,765.00 the company is a steady performer amidst market fluctuations. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape, addressing the growing need for mental health services. Acadia Healthcare belongs to the Healthcare sector, driving innovation and growth as it advances its mission to provide quality care and improve outcomes for its patients. This essential role in the behavioral healthcare field positions it favorably for continued success and relevance in a rapidly evolving industry.
Is Acadia Healthcare Company, Inc. (ACHC) a good investment?
Investing in Acadia Healthcare Company, Inc. (ACHC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bearish outlook. Always conduct your own research before investing.
What is Acadia Healthcare Company, Inc. (ACHC)'s stock forecast?
Analysts predict Acadia Healthcare Company, Inc. stock to fluctuate between $11.43 (low) and $31.04 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Acadia Healthcare Company, Inc.'s market capitalization?
As of 2026-03-27, Acadia Healthcare Company, Inc.'s market cap is $2,112,571,765, based on 92,211,775 outstanding shares.
How does Acadia Healthcare Company, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Acadia Healthcare Company, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Acadia Healthcare Company, Inc. (ACHC) stock?
To buy Acadia Healthcare Company, Inc. (ACHC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ACHC. Place an order (Market, Limit, etc.).
What is the best time to invest in Acadia Healthcare Company, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Acadia Healthcare Company, Inc. stock ever split?
Acadia Healthcare Company, Inc.'s last stock split was 1:4 on 2011-11-01.
How did Acadia Healthcare Company, Inc. perform in the last earnings report?
Revenue: $3,312,769,000 | EPS: -$12.16 | Growth: -535.84%.
Where can I find Acadia Healthcare Company, Inc.'s investor relations reports?
Visit https://www.acadiahealthcare.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Acadia Healthcare Company, Inc.?
You can explore historical data from here
What is the all-time high and low for Acadia Healthcare Company, Inc. stock?
All-time high: $89.85 (2022-11-30) | All-time low: $11.43 (2026-01-15).
What are the key trends affecting Acadia Healthcare Company, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?
defenseworld.net
Shares of Acadia Healthcare Company, Inc. (NASDAQ: ACHC - Get Free Report) have been assigned a consensus recommendation of "Hold" from the sixteen research firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a
seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Presents at Leerink Global Healthcare Conference 2026 Transcript
fool.com
Canyon Capital sold 521,774 shares of Acadia Healthcare in the fourth quarter. The quarter-end position value fell by approximately $12.92 million as a result.
seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
seekingalpha.com
Acadia Healthcare Company, Inc. maintains a Buy rating as new CEO Debbie Osteen focuses on operational stability and disciplined capital allocation amid ongoing industry headwinds. ACHC 2025 revenues reached $3.3bn with adjusted EBITDA of $609m, but a net loss of $1.1bn was driven by a non-cash goodwill impairment. 2026 guidance projects modest revenue growth to $3.37–$3.45bn, adjusted EBITDA of $575–$610m, and EPS decline, reflecting a reset year with limited organic volume growth.
seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Q4 2025 Earnings Call Transcript
benzinga.com
The stock is moving higher as the broader market is experiencing gains, with the Nasdaq up 1.23%.
seekingalpha.com
Acadia Healthcare is rated Buy, driven by a record-low valuation post-2011 merger and a massive 29% short interest poised for a potential squeeze. ACHC trades at 6.5x EV/EBITDA and 1.2x EV/sales, far below its 10-year medians and current peer ratios, with steady earnings projected during 2026-27. Management slashed CapEx by $300M for 2026, aiming to stabilize cash flows and address debt concerns, while a new CEO and activist investors add confidence in a turnaround.
See all news
